[Factors associated with FEV1 evolution in cystic fibrosis patients treated by CFTR modulator tritherapy]
{{output}}
Introduction: Triple therapy with Elexacaftor, Tezacaftor and Ivacaftor (ETI) has transformed the management of cystic fibrosis. The aim of this study was to describe the patients under treatment who do not show improvement in FE... ...
